AstraZeneca Pty Ltd, Alma Road, North Ryde NSW 2113, Australia. ABN 54 009 682 311.
emla® is a registered trademark of AstraZeneca Pty Ltd.
References: 1. emla® Approved Product Information, March 2010. 2. Data on File at AstraZeneca Pty Ltd.
*Vaccination process.
Always read the label before using emla®. Use only as directed. See leaflet for further information.
Indications for emla®: Topical anaesthesia of the skin prior to vaccination. Active Ingredients: lignocaine 2.5% and prilocaine 2.5%.
All information displayed in this site is intended for Australian residents only and is not designed to replace the advice of your doctor or healthcare professional.
The use of and access to the information on this site is subject to the terms and conditions to use this website. Please read the legal agreement and privacy policy.
